The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)
Open accessAbstract
Migraine is a disabling neurological disease that affects 14.7 % of Europeans. Studies evaluating the economic impact of migraine are complex to conduct adequately and with time become outdated as healthcare systems evolve. This study sought to quantify and compare direct medical costs of chronic migraine (CM) and episodic migraine (EM) in five European countries. Cross-sectional data collected via a web-based survey were screened for migraine and classified as CM (≥15 headache days/month) or EM (<15 headache days/month), and included sociodemographics, resource use data and medication use. Unit cost data, gathered using publicly available sources, were analyzed for each type of service, stratified by migraine status. Univariate and multivariate log-normal regression models were used to examine the relationship between various factors and their impact on total healthcare costs. This economic analysis included data from respondents with migraine in the UK, France, Germany, Italy, and Spain. CM participants had higher level of disability and more prevalent psychiatric disorders compared to EM. CM participants had more provider visits, emergency department/hospital visits, and diagnostic tests; the medical costs were three times higher for CM than EM. Per patient annual costs were highest in the UK and Spain and lower in France and Germany. CM was associated with higher medical resource use and total costs compared to EM in all study countries, suggesting that treatments that reduce headache frequency could decrease the clinical and economic burden of migraine in Europe. Comparing patterns of care and outcomes among countries may facilitate the development of more cost-effective care, and bring greater recognition to patients affected by migraine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, no detailed assessment of the current treatment pathway, impact on work productivity, or burden associated with premonitory and postdromal phases of migraine is available in individuals experiencing ≥4 MMDs who have had previous prophylactic treatments that failed and continue to experience frequent migraines.”
From My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed (2018) · cites this paper as [6]
In the citing paper
“However, the current understanding of migraine burden among individuals with the highest unmet needs, specifically those experiencing ≥4 monthly migraine days (MMDs) and prior prophylaxis failure, is limited.”
From My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed (2018) · cites this paper as [6]
In the citing paper
“These findings are consistent with the results of the IBMS study, which found that for each of the five European countries studied, chronic migraine (per ICHD-2 criteria, persons with ≥15 MMDs) was associated with additional healthcare costs attributable to an increased use of medical services and associated cost [6].”
From My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed (2018) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
Lipton, R. B., Stewart, W. F., Diamond, S., Diamond, M. L., & Reed, M. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041007646.x · Cited by 2,268
Self-citationStewart, W. F., Lipton, R. B., Dowson, A. J., & Sawyer, J. (2001) · Neurology · doi:10.1212/wnl.56.suppl_1.s20 · Cited by 1,210
Self-citationNew Appendix Criteria Open for a Broader Concept of Chronic Migraine
Olesen, J., Bousser, M.-G., Diener, H.-C., Dodick, D., First, M., Goadsby, P., Göbel, H., Lainez, M., Lance, J., Lipton, R., et al. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2006.01172.x · Cited by 909 · cited 1×
“1 defines chronic migraine as C15 headache days per month for at least 3 months, with C8 days per month fulfilling criteria for migraine without aura, in the absence of medication overuse and that cannot be attributed to another causative disorder [6].”
BackgroundSelf-citationBIGAL, M. E., Serrano, D., Buse, D. C., Scher, I., Stewart, W. F., & Lipton, R. B. (2008) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01217.x · Cited by 848
Self-citationThe cost of headache disorders in Europe: the Eurolight project
Linde, M., Gustavsson, A., Stovner, L. J., Steiner, T. J., Barré, J., Katsarava, Z., Lainez, J. M., Lampl, C., Lantéri‐Minet, M., Rastenyte, D., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03612.x · Cited by 741
Self-citationGlobal prevalence of chronic migraine: A systematic review
Natoli, J. L., Manack, A., Dean, B. B., Butler, Q. R., Turkel, C., Stovner, L., & Lipton, R. B. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2009.01941.x · Cited by 693
Self-citationAn international study to assess reliability of the Migraine Disability Assessment (MIDAS) score
Stewart, W. F., Lipton, R. B., Whyte, J., Dowson, A. J., Kolodner, K. B., Liberman, J. N., & Sawyer, J. P. C. (1999) · Neurology · doi:10.1212/wnl.53.5.988 · Cited by 629
Self-citationBlumenfeld, A., Varon, S., Wilcox, T., Buse, D., Kawata, A., Manack, A., Goadsby, P., & Lipton, R. (2011) · Cephalalgia · doi:10.1177/0333102410381145 · Cited by 627
Self-citationSociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
Buse, D. C., Manack, A., Serrano, D., Turkel, C., & Lipton, R. B. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.192492 · Cited by 622
Self-citationClassification of daily and near-daily headaches
Silberstein, S. D., Lipton, R. B., & Sliwinski, M. J. (1996) · Neurology · doi:10.1212/wnl.47.4.871 · Cited by 613
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Reed ML, Buse DC, Manack AN, Fanning KM, Serrano D, Turkel CC, Lipton RB (2011) Prevalence of chronic migraine (CM), headache-related disability and sociodemographic factors in the US population. Headache 51(S1):28
- Michel P, Auray J, Chicoye A, Dartigues J, Lamure M, Duru G, Henry P, Salamon R (1993) Prise en charge des migraineux en France: coût et recours aux soins. J d’Econ Méd 11:71–80
Cited by
Sorted by citations
Items 101–200 of 336
Migraine in university students: A systematic review and meta‐analysis
Flynn, O., Fullen, B. M., & Blake, C. M. (2022) · European Journal of Pain · doi:10.1002/ejp.2047 · Cited by 28
Esserlind, A.-L., Christensen, A. F., Steinberg, S., Grarup, N., Pedersen, O. B., Hansen, T. F., Werge, T. M., Hansen, T. F., Husemoen, L. L. N., Linneberg, A. R., et al. (2015) · Cephalalgia · doi:10.1177/0333102415570492 · Cited by 28
The effect of cigarette smoking on retinal nerve fiber layer thickness in patients with migraine
Demirci, S., Gunes, A. S., Demirci, S., Kutluhan, S., Tök, L., & Tök, Ö. (2015) · Cutaneous and Ocular Toxicology · doi:10.3109/15569527.2014.1003935 · Cited by 28
Therapie und Versorgung bei chronischer Migräne
Straube, A. M., Gaul, C., Förderreuther, S., Kropp, P. A., Marziniak, M., Evers, S., Jost, W. H., Göbel, H., Lampl, C., Sándor, P. S., et al. (2012) · Der Nervenarzt · doi:10.1007/s00115-012-3680-9 · Cited by 27
Evaluating Migraineurs' Preferences for Migraine Treatment Outcomes Using a Choice Experiment
González, J. M., Johnson, F. R., Runken, M. C., & Poulos, C. M. (2013) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12142 · Cited by 26
Use and overuse of triptans in Austria – a survey based on nationwide healthcare claims data
Zebenholzer, K., Gall, W., & Wöber, C. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0864-0 · Cited by 26
The Health and Productivity Burden of Migraines in Australia
Tu, S., Liew, D., Ademi, Z., Owen, A. J., & Zomer, E. (2020) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13969 · Cited by 26
Ailani, J., Andrews, J. S., Rettiganti, M. R., & Nicholson, R. A. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01190-7 · Cited by 26
Lantéri‐Minet, M., Demarquay, G., Alchaar, H., Bonnin, J., Cornet, P., Douay, X., Dousset, V., Géraud, G., Guillouf, V., Navez, M. L., et al. (2014) · Revue Neurologique · doi:10.1016/j.neurol.2013.09.006 · Cited by 26
Sumelahti, M., Sumanen, M. P. T., Sumanen, M. S., Tuominen, S., Vikkula, J., Honkala, S. M., Rosqvist, S., & Korolainen, M. A. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01185-4 · Cited by 26
Sumatriptan plus naproxen for acute migraine attacks in adults
Law, S., Derry, S., & Moore, R. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008541.pub2 · Cited by 26
Martelletti, P., Schwedt, T. J., Vo, P. G., Ritrovato, D., Reilly, M. C., Naclerio, M., Ranjan, P., Kleebach, J., & Joshi, P. (2021) · Journal of Medical Economics · doi:10.1080/13696998.2021.1925557 · Cited by 25
Self-citationGlucose-Related Traits and Risk of Migraine—A Potential Mechanism and Treatment Consideration
Islam, M. R., & Nyholt, D. R. (2022) · Genes · doi:10.3390/genes13050730 · Cited by 26
Raciti, L., Raciti, G., Militi, D., Casella, C., & Calabrò, R. S. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2105141 · Cited by 24
Real-world evidence on the economic implications of CGRP-mAbs as preventive treatment of migraine
Siersbæk, N., Kilsdal, L., Jervelund, C., Antić, S., & Bendtsen, L. (2023) · BMC Neurology · doi:10.1186/s12883-023-03302-7 · Cited by 24
Griep, R. H., Toivanen, S., Santos, I. S., Rotenberg, L., Juvanhol, L. L., Goulart, A. C., Aquino, E. M. L., & Benseñor, I. M. (2016) · American Journal of Industrial Medicine · doi:10.1002/ajim.22620 · Cited by 24
Przeklasa-Muszyńska, A., Skrzypiec, K., Kocot-Kępska, M., Dobrogowski, J., Wiatr, M., & Mika, J. (2017) · Neurologia i Neurochirurgia Polska · doi:10.1016/j.pjnns.2017.01.004 · Cited by 24
Association Between Migraine and Suicidal Behaviors: A Nationwide Study in the USA
Friedman, L. E., Zhong, Q., Gelaye, B., Williams, M. A., & Peterlin, B. L. (2017) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13235 · Cited by 24
Targets for migraine treatment: beyond calcitonin gene-related peptide
Moreno‐Ajona, D., Villar‐Martínez, M. D., & Goadsby, P. J. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000935 · Cited by 25
Self-citationKollewe, K., Gaul, C., Gendolla, A., & Sommer, K. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01260-4 · Cited by 23
Streel, S., Donneau, A., Hoge, A., Albert, A., Schoenen, J. E., & Guillaume, M. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.04.009 · Cited by 23
Sodium channel antagonists for the treatment of migraine
Chiossi, L., Negro, A., Capi, M., Lionetto, L., & Martelletti, P. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.929665 · Cited by 23
Self-citationErenumab in the Treatment of Migraine
Jain, S., Yuan, H., Spare, N. M., & Silberstein, S. D. (2018) · Pain Management · doi:10.2217/pmt-2018-0037 · Cited by 23
A Critical Evaluation on MOH Current Treatments
Negro, A., Curto, M., Lionetto, L., Guérzoni, S., Pini, L. A., & Martelletti, P. (2017) · Current Treatment Options in Neurology · doi:10.1007/s11940-017-0465-2 · Cited by 21
Self-citationAssociation of migraines with brain tumors: a nationwide population-based study
Chen, C.-H., Sheu, J., Lin, Y.-C., & Lin, H. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0944-1 · Cited by 21
Validation of an extended French version of ID Migraine™ as a migraine-screening tool
Streel, S., Donneau, A., Dardenne, N., Hoge, A., Bruyère, O., Albert, A., Guillaume, M., & Schoenen, J. E. (2014) · Cephalalgia · doi:10.1177/0333102414544910 · Cited by 21
Migraine associated with gastrointestinal disorders: A pathophysiological explanation
Noghani, M. T., & Namdar, H. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.02.041 · Cited by 21
The burden of migraine on acute and emergency services in a London teaching hospital
Southwell, J. E., & Afridi, S. K. (2021) · Cephalalgia · doi:10.1177/0333102420981734 · Cited by 20
Newman, L. C., Vo, P. G., Zhou, L., López, C. L., Cheadle, A., Olson, M. S., & Fang, J. (2021) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000001076 · Cited by 20
Lattanzi, S., Trinka, E., Altamura, C., Giovane, C. D., Silvestrini, M., Brigo, F., & Vernieri, F. (2022) · Neurology and Therapy · doi:10.1007/s40120-022-00370-8 · Cited by 20
Schwedt, T. J., Lee, J. C., Knievel, K. L., McVige, J. W., Wang, W., Wu, Z., Gillard, P. J., Shah, D., & Blumenfeld, A. M. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.29.10.1119 · Cited by 20
Self-citationDeng, X., Zhou, L., Liang, C., Shang, X., Xu, H., Liu, W., Liang, S., Wang, Y., Xu, M., Guo, K., et al. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01723-4 · Cited by 21
Evidencia y experiencia de bótox en migraña crónica: Recomendaciones para la práctica clínica diaria
Gago‐Veiga, A. B., Lasaosa, S. S., Cuadrado, M. L., Guerrero, Á. L., Irimia, P., Laínez, J. M., Leira, R., Pascual, J., del Río, M. S., Viguera, J., et al. (2017) · Neurología · doi:10.1016/j.nrl.2017.09.008 · Cited by 20
Self-citationGenes and primary headaches: discovering new potential therapeutic targets
Rainero, I., Rubino, E., Paemeleire, K., Gai, A., Vacca, A., Martino, P. D., Gentile, S., Sarchielli, P., & Pinessi, L. (2013) · The Journal of Headache and Pain · doi:10.1186/1129-2377-14-61 · Cited by 20
Ruíz, M., Mulero, P., Hueso, M. I. P., Rodríguez, C. D. L. C., Mesonero, L. L., & Peral, Á. L. G. (2014) · Neurología · doi:10.1016/j.nrl.2014.10.001 · Cited by 19
Li, G., Duan, S., Zhu, T., Ren, Z., Xia, H., Wang, Z., Liu, L., & Liu, Z. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01662-6 · Cited by 18
The Use of Botulinum Toxin in the Management of Headache Disorders
Silberstein, S. D. (2016) · Seminars in Neurology · doi:10.1055/s-0036-1571443 · Cited by 18
Association between Cervical Spondylosis and Migraine: A Nationwide Retrospective Cohort Study
Lin, W., Huang, T., Chuang, T., Lin, C., & Kao, C. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15040587 · Cited by 18
A replication study separates polymorphisms behind migraine with and without depression
Petschner, P., Baksa, D., Hullám, G., Török, D., Millinghoffer, A., Deakin, J. F. W., Bagdy, G., & Juhász, G. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261477 · Cited by 18
Development and validation of the ID-EC - the ITALIAN version of the identify chronic migraine
Sacco, S., Benemei, S., Cevoli, S., Coppola, G., Cortelli, P., Cesaris, F. D., Icco, R. D., Marco, C. M. D., Lorenzo, C. D., Geppetti, P., et al. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0966-3 · Cited by 17
Self-citationThe molecular pathogenesis of migraine: new developments and opportunities
Cader, M. Z. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt364 · Cited by 18
Ayele, B. A., & Yifru, Y. M. (2018) · BMC Neurology · doi:10.1186/s12883-018-1095-3 · Cited by 16
Filipović, B., de Ru, J. A., van de Langenberg, R., Borggreven, P. A., Lacković, Z., & Lohuis, P. J. F. M. (2017) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-017-4450-x · Cited by 16
García‐Azorín, D., Yamani, N., Messina, L. M., Peeters, I., Ferrili, M. J., Ovchinnikov, D. A., Speranza, M. L., Marini, V., Negro, A., Benemei, S., et al. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0920-9 · Cited by 16
Migraine burden and costs in France: a nationwide claims database analysis of triptan users
Donnet, A., Emery, C., Aly, S., Allaf, B., Cayre, F., Mahieu, N., Gourmelen, J., Levy, P., & Fagnani, F. (2019) · Journal of Medical Economics · doi:10.1080/13696998.2019.1590841 · Cited by 16
The association between ambient air pollution and migraine: a systematic review
Sabour, S., Harzand-Jadidi, S., Jafari-Khounigh, A., Gavgani, V. Z., Sedaghat, Z., & Alavi, N. (2024) · Environmental Monitoring and Assessment · doi:10.1007/s10661-024-12376-w · Cited by 15
Internationale Klassifikation von Kopfschmerzerkrankungen
Göbel, H., & Evers, S. (2019) · Nervenheilkunde · doi:10.1055/a-0930-5739 · Cited by 15
Real-world migraine burden: clinical and economic aspects
Наприенко, М. В., Smekalkina, L. V., Сафонов, М. И., Filatova, E. G., Владимировна, Л. Н., Ekusheva, E. V., Artemenko, A. R., Osipova, V. В., & Baiushkina, L. I. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201911901131 · Cited by 14
Darbà, J., & Marsà, A. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034926 · Cited by 14
Souza, J. S., Reis, E. A., Godman, B., Campbell, S., Meyer, J. C., de Sena, L. W. P., & Godói, I. P. D. (2024) · Annals of Pharmacy Education Safety and Public Health Advocacy · doi:10.51847/eewktbkvgk · Cited by 14
Impacto y situación de la Migraña en España: Atlas 2018
Garrido‐Cumbrera, M. (2019) · Editorial Universidad de Sevilla eBooks · doi:10.12795/9788447228324 · Cited by 14
Headache for ophthalmologists: current advances in headache understanding and management
Mollan, S. P., Virdee, J. S., Bilton, E. J., Thaller, M., Krishan, A., & Sinclair, A. J. (2021) · Eye · doi:10.1038/s41433-021-01421-4 · Cited by 14
Indirect costs attributed to headache: A nation-wide survey of an active working population
Gil‐Gouveia, R., & Miranda, R. (2021) · Cephalalgia · doi:10.1177/03331024211043795 · Cited by 14
The first report of the Italian Migraine Registry (I-GRAINE)
Barbanti, P., Egeo, G., Aurilia, C., Fiorentini, G., Proietti, S., Tomino, C., Bonassi, S., for the Italian Migraine Registry Study Group, Albanese, M., Allais, G., et al. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06214-5 · Cited by 14
Características de los 2.000 primeros pacientes registrados en una consulta monográfica de cefaleas
Pedraza, M. I., Mulero, P., Ruíz, M., de la Cruz, C., Herrero, S., & Peral, Á. L. G. (2014) · Neurología · doi:10.1016/j.nrl.2013.12.010 · Cited by 14
Dietary Intake of Thiamine in Migraine Patients and Healthy Subjects: a Case-Control Study
Faraji, H., Paknahad, Z., & Chitsaz, A. (2018) · Clinical Nutrition Research · doi:10.7762/cnr.2018.7.1.40 · Cited by 14
Functional Imaging in Chronic Migraine
Maniyar, F., & Goadsby, P. J. (2013) · Current Pain and Headache Reports · doi:10.1007/s11916-013-0333-z · Cited by 14
Self-citationDodick, D. W., Reed, M. L., Lee, L., Balkaran, B. L., Umashankar, K., Parikh, M., Gandhi, P., & Buse, D. C. (2024) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14684 · Cited by 13
Self-citationMistry, H., Naghdi, S., Brown, A., Rees, S., Madan, J. J., Grove, A., Khanal, S., Duncan, C. N., Matharu, M. S., Cooklin, A., et al. (2024) · Health Technology Assessment · doi:10.3310/aywa5297 · Cited by 14
Pericranial nerve blockade as a preventive treatment for migraine: Experience in 60 patients
Piñero, M. R., Mulero, P., Hueso, M. I. P., Rodríguez, C. D. L. C., Mesonero, L. L., & Peral, Á. L. G. (2016) · Neurología (English Edition) · doi:10.1016/j.nrleng.2016.07.001 · Cited by 13
Serum lipid profile in migraine and its association with clinical characteristics
Uygur-Kucukseymen, E., & Akça, G. (2022) · Neurological Research · doi:10.1080/01616412.2022.2119723 · Cited by 12
Muñoz‐Gómez, E., Rodríguez, M. A., Serra‐Añó, P., Rubio, N. S., Mollà‐Casanova, S., & Inglés, M. (2023) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2022-0152 · Cited by 12
Silberstein, S. D. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1339600 · Cited by 12
The clinical and public health implications and risks of widening the definition of chronic migraine
Guglielmetti, M., Raggi, A., Ornello, R., Sacco, S., D’Amico, D., Leonardi, M., & Martelletti, P. (2019) · Cephalalgia · doi:10.1177/0333102419895777 · Cited by 12
Self-citationFactors Associated with Incidental Neuroimaging Abnormalities in New Primary Headache Patients
Kim, B., Kim, S.-K., Kim, J.-M., Moon, H., Park, K., Park, J. W., Sohn, J., Song, T., Chu, M. K., Cha, M.-J., et al. (2020) · Journal of Clinical Neurology · doi:10.3988/jcn.2020.16.2.222 · Cited by 12
Spierings, E. L. H., Kärppä, M., Ning, X., Cohen, J. M., Campos, V. R., Yang, R., & Reuter, U. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01232-8 · Cited by 12
Gribbin, C., Dani, K., & Tyagi, A. (2021) · Neurology India · doi:10.4103/0028-3886.315972 · Cited by 12
Young, W. B. (1997) · PubMed · Cited by 12
Uses of Botulinum Toxin in Headache and Facial Pain Disorders: An Update
Rocha‐Filho, P. A. S., Dominguez, M., Robinson, C. L., & Ashina, S. (2025) · Toxins · doi:10.3390/toxins17070314 · Cited by 11
Epidemiology of migraine: French key descriptive data
Lantéri‐Minet, M., & Géraud, G. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.07.012 · Cited by 11
Vo, P. G., Gao, W., Zichlin, M. L., Fuqua, E., Fadli, E., Vázquez, M. A., Tarancón, T., Mahieu, N., Maier‐Peuschel, M., Rossi, S., et al. (2019) · Journal of Medical Economics · doi:10.1080/13696998.2019.1636051 · Cited by 11
Vo, P. G., Swallow, E., Wu, E. Q., Zichlin, M. L., Katcher, N., Maier‐Peuschel, M., Naclerio, M., Ritrovato, D., Tiwari, S., Joshi, P., et al. (2021) · Journal of Medical Economics · doi:10.1080/13696998.2021.1953301 · Cited by 11
Martins, R., Large, S., Russell, R. J., Surmay, G., & Connolly, M. P. (2023) · Journal of health economics and outcomes research · doi:10.36469/jheor.2023.87790 · Cited by 11
Şengül, Y., Sengul, H., Bakım, B., Yucekaya, S. K., Yücel, S., & Akgün, M. (2014) · Sleep and Biological Rhythms · doi:10.1111/sbr.12087 · Cited by 11
Stress Is Associated with Poor Outcome of Acute Treatment for Chronic Migraine: A Multicenter Study
Cha, M.-J., Kim, B., Moon, H., Ahn, J. Y., Oh, K., Kim, J. Y., Kim, B., Sohn, J., Chung, J.-M., Song, T., et al. (2017) · Pain Medicine · doi:10.1093/pm/pnx269 · Cited by 11
Wachholtz, A., Vohra, R., & Metzger, A. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.08.011 · Cited by 11
Davidson, I., Crooks, K., Newington, L., Pilling, M. A., & Todd, C. J. (2018) · International Journal of Therapy and Rehabilitation · doi:10.12968/ijtr.2018.25.8.382 · Cited by 10
Characteristics of the first 2000 patients registered in a specialist headache clinic
Pedraza, M. I., Mulero, P., Ruíz, M., de la Cruz, C., Herrero, S., & Guerrero, A. L. (2015) · Neurología (English Edition) · doi:10.1016/j.nrleng.2015.03.002 · Cited by 10
Unique Considerations for Special Populations in Episodic Migraine: the Underserved
Najib, U., Moore, M., & Watson, D. (2019) · Current Pain and Headache Reports · doi:10.1007/s11916-019-0749-1 · Cited by 10
Manual therapy for chronic migraine: a pragmatic randomised controlled trial study protocol
Odell, J., Clark, C., Hunnisett, A., Ahmed, O. H., & Branney, J. (2019) · Chiropractic & Manual Therapies · doi:10.1186/s12998-019-0232-4 · Cited by 10
Barbanti, P., Fofi, L., Grazzi, L., Vernieri, F., Camarda, C., Torelli, P., Cevoli, S., Russo, A., Bono, F., Finocchi, C., et al. (2021) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14123 · Cited by 10
Gago‐Veiga, A. B., Lasaosa, S. S., Cuadrado, M. L., Guerrero, Á. L., Irimia, P., Lainez, J. M., Leira, R., Pascual, J., del Río, M. S., Viguera, J., et al. (2019) · Neurología (English Edition) · doi:10.1016/j.nrleng.2019.02.008 · Cited by 10
Self-citationDevelopment of a measure of self-efficacy for acute headache medication adherence
Seng, E. K., Nicholson, R. A., & Holroyd, K. A. (2015) · Journal of Behavioral Medicine · doi:10.1007/s10865-015-9683-9 · Cited by 10
Brüggenjürgen, B., Baker, T., Bhogal, R., & Ahmed, F. (2016) · SpringerPlus · doi:10.1186/s40064-016-2924-8 · Cited by 10
Seifert, L. S., & Seifert, C. A. (2017) · Current Psychology · doi:10.1007/s12144-017-9676-7 · Cited by 10
The therapeutic potential of novel anti-migraine acute therapies
Sabato, D., Lionetto, L., & Martelletti, P. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.983223 · Cited by 10
Self-citationPérez‐Pereda, S., Toriello, M., González‐Quintanilla, V., Gómez, J. P., & Durán, A. O. (2019) · Revista de Neurología · doi:10.33588/rn.6812.2018502 · Cited by 9
Changes in peripheral and central sensitization in patients undergoing occipital nerve stimulation
Wodehouse, T., Bahra, A., & Mehta, V. (2019) · British Journal of Pain · doi:10.1177/2049463719860548 · Cited by 9
Acupuncture reduced the medical expenditure in migraine patients
Tsai, S.-T., Tseng, C., Lin, M., Liao, H.-Y., Teoh, B. K., San, S., Tsai, C., Huang, H.-Y., & Lin, Y. (2020) · Medicine · doi:10.1097/md.0000000000021345 · Cited by 9
Benchmarking European Home Care Models for Older Persons on Societal Costs: The IBenC Study
van Lier, L. I., van der Roest, H. G., Garms-Homolová, V., Onder, G., Jónsson, P. V., Declercq, A., Hertogh, C. M. P. M., van Hout, H. P. J., & Bosmans, J. E. (2021) · Health Services Insights · doi:10.1177/11786329211022441 · Cited by 9
Rua, T., Mazumder, A., Akande, Y., Margariti, C., Ochulor, J., Turville, J., Razavi, R., Peacock, J. L., McCrone, P., Goh, V., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-036097 · Cited by 9
Total health insurance costs in children with a migraine diagnosis compared to a control group
Obermeier, V., Murawski, M., Heinen, F., Landgraf, M. N., Straube, A. M., von Kries, R., & Ruscheweyh, R. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01349-w · Cited by 9
Tatarinova, K., & Artemenko, A. R. (2017) · Neuromuscular Diseases · doi:10.17650/2222-8721-2017-7-1-43-53 · Cited by 8
The Use of Botulinum Toxin in the Management of Headache Disorders
Yuan, H., & Silberstein, S. D. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_365 · Cited by 8
Onabotulinumtoxin A (ONA-BoNT/A) in the treatment of chronic migraine
Domitrz, I., Sławek, J., Słowik, A., Boczarska-Jedynak, M., Stępień, A., Rejdak, K., Gierczyński, J., & Rożniecki, J. (2021) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2021.0061 · Cited by 8
Lyu, S., Zhang, C. S., Zhang, A. L., Guo, X., Hua, R., Mao, Z., Su, Q., Xue, C. C., & Sun, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1330589 · Cited by 8
Practical Insights on the Identification and Management of Patients with Chronic Migraine
Blumenfeld, A. M., Dueland, A. N., Evers, S., Jenkins, B., Martelletti, P., & Sommer, K. (2022) · Pain and Therapy · doi:10.1007/s40122-022-00387-9 · Cited by 8
Self-citationTreatment of menstrual migraine: utility of control of related mood disturbances
Negro, A., Napoletano, F., Lionetto, L., Marsibilio, F., Sani, G., Girardi, P., & Martelletti, P. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.906304 · Cited by 8
Self-citationEmerging Targets for Migraine Treatment
Moreno‐Ajona, D., Villar‐Martínez, M. D., & Goadsby, P. J. (2021) · Neurology India · doi:10.4103/0028-3886.315989 · Cited by 8
Self-citationAcute treatment of migraine: quo vadis?
Martelletti, P. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1329821 · Cited by 8
Self-citation
Metadata
- Authors
- Bloudek, L. M., Stokes, M., Buse, D. C., Wilcox, T. K., Lipton, R. B., Goadsby, P. J., Varon, S. F., Blumenfeld, A. M., Katsarava, Z., Pascual, J., Lanteri-Minet, M., Cortelli, P., & Martelletti, P.
- Affiliations
- Allergan (United States) (US)
- Albert Einstein College of Medicine (US)
- University of California, San Francisco (US)
- Essen University Hospital (DE)
- Hospital Universitario Central de Asturias (ES)
- University of Bologna (IT)
- Azienda Ospedaliera Sant'Andrea (IT)
- Corresponding author
- Bloudek, L. M.
- ORCID
- Venue
- The Journal of Headache and Pain
- Published
- 2012-05-29
- Volume
- 13
- Issue
- 5
- Pages
- 361-378
- ISSN
- 1129-2369 (ISSN-L)
- 1129-2377
- PMC
- PMC3381065
- OpenAlex
- W2094473459
- Cited by
- 339
- References
- 38
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 26 · 2023: 19 · 2022: 18 · 2021: 38 · 2020: 36 · 2019: 34 · 2018: 25 · 2017: 25 · 2016: 17 · 2015: 17 · 2014: 30 · 2013: 25 · 2012: 6
- FWCI
- 17.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- The Journal of Headache and Pain (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Portal (King's College London) (publishedVersion, other-oa)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- eScholarship (California Digital Library) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- University of Washington
- Allergan
- Topics
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Keywords
- migraine, chronic migraine, episodic migraine, health care costs, direct medical costs, health care utilization, disability, psychiatric comorbidity, emergency department visits, hospital visits, diagnostic testing, medication use, cross-national comparison
- MeSH terms
- Cross-Sectional Studies, Europe, Female, Persons with Disabilities, Health Surveys, Humans, Male, Migraine Disorders, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
